Genome-wide association studies in pharmacogenomics of antidepressants (Q38444447)

3 September 2017

0 references

1 reference

title

Genome-wide association studies in pharmacogenomics of antidepressants (English)

1 reference

genome-wide association study

3 September 2017

0 references

1 reference

Eugene Lin

1

1 reference

PubMed ID

25916525

3 September 2017

Hsien-Yuan Lane

series ordinal

2

1 reference

3 September 2017

1 April 2015

1 reference

3 September 2017

1 reference

3 September 2017

16

1 reference

3 September 2017

5

1 reference

3 September 2017

555-566

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

3 September 2017

1 reference

Pharmacogenomics with antidepressants in the STAR*D study

21 January 2018

1 reference

Genome-wide QTL mapping for three traits related to teat number in a White Duroc x Erhualian pig resource population

21 January 2018

1 reference

How to interpret a genome-wide association study

21 January 2018

1 reference

Common genetic variation and human traits

21 January 2018

1 reference

Genome-wide association studies in diverse populations

21 January 2018

1 reference

Using genome-wide pathway analysis to unravel the etiology of complex diseases.

21 January 2018

1 reference

Prioritizing GWAS results: A review of statistical methods and recommendations for their application

21 January 2018

1 reference

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

21 January 2018

1 reference

A genomewide association study of citalopram response in major depressive disorder

21 January 2018

1 reference

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

21 January 2018

1 reference

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis

21 January 2018

1 reference

A genome-wide association study of a sustained pattern of antidepressant response

21 January 2018

1 reference

Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

21 January 2018

1 reference

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

21 January 2018

1 reference

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients

21 January 2018

1 reference

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.

21 January 2018

1 reference

Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma

21 January 2018

1 reference

Genome-wide association study of schizophrenia in a Japanese population

21 January 2018

1 reference

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

A genomewide association study of citalopram response in major depressive disorder-a psychometric approach

21 January 2018

1 reference

Association analysis of UBE3C polymorphisms in Korean aspirin-intolerant asthmatic patients

21 January 2018

1 reference

Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression

21 January 2018

1 reference

Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorder

21 January 2018

1 reference

A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus

21 January 2018

1 reference

PER2 variantion is associated with depression vulnerability.

21 January 2018

1 reference

Genome-wide association scan of trait depression

21 January 2018

1 reference

Race, genetic ancestry and response to antidepressant treatment for major depression

21 January 2018

1 reference

Nervous system proteoglycans as modulators of neurite outgrowth

21 January 2018

1 reference

Genome-wide scan of job-related exhaustion with three replication studies implicate a susceptibility variant at the UST gene locus

21 January 2018

1 reference

CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro

21 January 2018

1 reference

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.

21 January 2018

1 reference

DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP

21 January 2018

1 reference

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies

21 January 2018

1 reference

Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome

21 January 2018

1 reference

The Human Phosphatidylinositol Phosphatase SAC1 Interacts with the Coatomer I Complex

21 January 2018

1 reference

Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary

21 January 2018

1 reference

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

Depression, antidepressants and suicidality: a critical appraisal

21 January 2018

1 reference

Papilin, a novel component of basement membranes, in relation to ADAMTS metalloproteases and ECM development

21 January 2018

1 reference

Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia

21 January 2018

1 reference

Interpreting noncoding genetic variation in complex traits and human disease

21 January 2018

1 reference

Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip

21 January 2018

1 reference

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study

21 January 2018

1 reference

Finding the missing heritability of complex diseases

21 January 2018

1 reference

Uncovering the roles of rare variants in common disease through whole-genome sequencing

21 January 2018

1 reference

The complete genome of an individual by massively parallel DNA sequencing

21 January 2018

1 reference

Exome sequencing as a tool for Mendelian disease gene discovery

21 January 2018

1 reference

Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C.

21 January 2018

1 reference

Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension

21 January 2018

1 reference

Pattern-recognition techniques with haplotype analysis in pharmacogenomics

21 January 2018

1 reference

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond

21 January 2018

1 reference

Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression

21 January 2018

1 reference

Translating pharmacogenomics: challenges on the road to the clinic

21 January 2018

1 reference

Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?

21 January 2018

1 reference

Science and commerce. Gene tests for psychiatric risk polarize researchers.

21 January 2018

1 reference

Stakeholder views on pharmacogenomic testing.

21 January 2018

1 reference

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

21 January 2018

1 reference

A whole genome association study of neuroticism using DNA pooling

21 January 2018

1 reference

Epigenetic mechanisms in mood disorders: targeting neuroplasticity

21 January 2018

1 reference

An artificial neural network approach to the drug efficacy of interferon treatments

21 January 2018

1 reference

Neural network analysis in pharmacogenetics of mood disorders

21 January 2018

1 reference

A Bayesian approach to gene-gene and gene-environment interactions in chronic fatigue syndrome

21 January 2018

1 reference

What Genome-wide Association Studies Can Do for Medicine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.15.5

1 reference

3 September 2017

1 reference

PubMed ID

25916525